Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Virology Follow up Study in Subjects Previously Treated With Telaprevir

NCT00916474

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Alabama Birmingham, Alabama, United States

California Coronado, California, United States

California Los Angeles, California, United States

California San Francisco, California, United States

View all 41 locations

View Trial Details

Completed

HIV Prevention for Injecting Drug Users in Kazakhstan

NCT01690442

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Global Health Research Center of Central Asia Almaty, Kazakhstan

View Trial Details

Completed

Dendritic Cell Vaccine in HIV-1 Infection

NCT00402142

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Hospital Clínic Barcelona, Spain

View Trial Details

Completed

Ribavirin Dose Optimization for the Treatment of Hepatitis C

NCT01289496

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Centre hospitalier de l'Université de Montréal Montreal, Quebec, Canada

View Trial Details

Completed

Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART

NCT01680094

Conditions: Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations: Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark

View Trial Details

Completed

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

NCT02069678

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong

View Trial Details

Completed

Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)

NCT01546116

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Chungbuk National University Hospital Cheongju-si, Chngcheongbuk-do, South Korea

Yonsei University Wonju Christian Hospital Wŏnju, Gangwon-do, South Korea

Korea University Ansan Hospital Ansan, Gyeonggi-do, South Korea

Hallym University, Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea

View Trial Details

Completed

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

NCT01582035

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Berlin, Germany

München, Germany

View Trial Details

Completed

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

NCT00445315

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Pfizer Investigational Site Brussels, Belgium

Pfizer Investigational Site Berlin, Germany

Pfizer Investigational Site Berlin, Germany

Pfizer Investigational Site Dundee, United Kingdom

View Trial Details

Completed

Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

NCT00994344

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

Hospital Universitario de Canarias Santa Cruz de Tenerife, Canary Islands, Spain

View Trial Details

Blood-Borne Infections

Blood-Borne Infections trial results

Related conditions